Manolo Carta, Ph.D.

Affiliations: 
2010- Biomedical Sciences Cagliari University 
Google:
"Manolo Carta"
Mean distance: 15.36 (cluster 11)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Scheggi S, Rossi F, Corsi S, et al. (2020) BDNF Overexpression Increases Striatal D3 Receptor Level at Striatal Neurons and Exacerbates D1-Receptor Agonist-Induced Dyskinesia. Journal of Parkinson's Disease
Meloni M, Puligheddu M, Sanna F, et al. (2020) Efficacy and safety of 5-Hydroxytryptophan on levodopa-induced motor complications in Parkinson's disease: A preliminary finding. Journal of the Neurological Sciences. 415: 116869
Carta G, Murru E, Vargiu R, et al. (2020) Essential fatty acids deficient diet modulates N-Acylethanolamide profile in rat's tissues. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 153: 102053
Nuzzo T, Punzo D, Devoto P, et al. (2019) The levels of the NMDA receptor co-agonist D-serine are reduced in the substantia nigra of MPTP-lesioned macaques and in the cerebrospinal fluid of Parkinson's disease patients. Scientific Reports. 9: 8898
Fanni S, Scheggi S, Rossi F, et al. (2018) 5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction. Neurobiology of Disease. 121: 120-130
Carta M, Björklund A. (2018) The serotonergic system in L-DOPA-induced dyskinesia: pre-clinical evidence and clinical perspective. Journal of Neural Transmission (Vienna, Austria : 1996)
Tronci E, Napolitano F, Muñoz A, et al. (2017) BDNF over-expression induces striatal serotonin fiber sprouting and increases the susceptibility to l-DOPA-induced dyskinesia in 6-OHDA-lesioned rats. Experimental Neurology
D Ko WK, Li Q, Yun Cheng L, et al. (2017) A preclinical study on the combined effects of repeated eltoprazine and preladenant treatment for alleviating L-DOPA-induced dyskinesia in Parkinson's disease. European Journal of Pharmacology
Frau R, Savoia P, Fanni S, et al. (2017) The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease. Experimental Neurology
Pinna A, Ko WK, Costa G, et al. (2016) Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society
See more...